Leen Majed Almaghyuli

Dr. Leen Majed Almaghyuli

Family Medicine Department, MENA Clinic, Saudi Arabia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Nada AlyousefiNada Alyousefi
Nada Alyousefi
LALeen Majed Almaghyuli
Leen Majed Almaghyuli
SASarah A Alsultan
Sarah A Alsultan
NANorah Ali Alshehri
Norah Ali Alshehri
AKAmbreen Kazi
Ambreen Kazi
LALemmese Alwatban
Lemmese Alwatban
Background/Objectives: Breast cancer is the most commonly diagnosed cancer among women in Saudi Arabia, yet evidence on younger women remains limited. This study aimed to characterize the clinicopathological, molecular, and treatment features of women diagnosed at age ≤ 40 years and to explore differences between women aged ≤ 35 and 36–40 years. Methods: We conducted a retrospective study of 135 women aged 22–40 years diagnosed with breast cancer at King Saud University Medical City, Riyadh. Variable-specific available-case denominators were used without imputation. Characteristics were summarized descriptively, and age groups were compared using Pearson’s chi-square or exact tests, as appropriate. Results: A breast mass was the most frequent presentation (79.3%), and invasive ductal carcinoma was the predominant diagnosis (80.7%). Tumors > 2 to ≤5 cm accounted for 48.9% of cases; axillary involvement was documented in 47.4%, distant metastasis in 16.7%, and grade 3 disease in 68.2% of patients with documented grade. Luminal B (31.5%) and triple-negative (29.2%) were the most frequently documented molecular subtypes. No statistically significant differences were detected between the age groups in clinical presentation, tumor-size category, axillary involvement, distant metastasis, histological grade, documented molecular subtype, or treatment characteristics. Conclusions: Symptomatic presentation and potentially unfavorable pathological features were common in this tertiary-center cohort. The absence of statistically significant clinicopathological, molecular, or treatment differences between age groups does not establish clinical equivalence and should be interpreted cautiously given the exploratory design and modest sample size. The findings highlight the need for standardized staging, hereditary-risk assessment, and multicenter longitudinal data to inform care for younger women with breast cancer.

30 November 2021 in Cureus
Verified
Journal Article
Open access
BABandar Saad Assakran
Bandar Saad Assakran
MAMansur Suliman Alqunai
Mansur Suliman Alqunai
AAAbdullah Homood Alromaih
Abdullah Homood Alromaih
LALaila M. Almutairi
Laila M. Almutairi
FAFai M. Alharbi
Fai M. Alharbi
LALeen Majed Almaghyuli
Leen Majed Almaghyuli
Introduction: Type two diabetes mellitus (T2DM) remission has been observed as an additional benefit of bariatric surgery for morbidly obese diabetic patients. There are many scoring systems for identifying factors that predict diabetes remission; however, there is as yet no universally applicable scoring system. Aim: This study aims to test the sensitivity of the DiaRem scoring system for predicting the resolution of T2DM in morbidly obese patients who underwent bariatric surgery at King Fahad Specialist Hospital in Buraydah, Saudi Arabia. Methods: This was a non-randomized controlled trial conducted at King Fand Specialist Hospital in Buraydah, Saudi Arabia. Visiting patients at first screening were enrolled based on eligibility criteria. Data were collected according to the given parameters such as gender, age, body mass index (BMI), duration of diabetes mellitus (DM), medications (insulin, oral antihyperglycemic agents, number of tablets if used, or no medications use), presence of comorbidities, such as hypertension and dyslipidemia, HbA1c level (before surgery and at third, sixth, and 12th months after surgery), and fasting blood glucose (FBG) level (before and after surgery). Results: A total of 96 diabetic patients were enrolled (35 males vs 61 females) with a mean age of 46.5 years. Laparoscopic sleeve gastrectomy was the most commonly performed surgery. The most common associated comorbidities were hypertension (50%) and hypothyroidism (14.6%). Results of the DiaRem scoring system showed 0-2 points in 15.6% patients, 3-7 points in 39.6% patients, 8-12 in 26% patients, 13-17 in 9.4% patients, and 18-22 in 9.4% patients. The lowest DiaRem score was associated with a higher value of BMI, shorter DM duration, and lower mean values of HbA1c and FBG post-surgery. Conclusion: Consistent with the literature, our results indicated that those with an increased BMI, shorter duration of DM, and lower values of HbA1c post-FBG had a greater chance of diabetes remission postoperatively.